Prospects for a novel vaccine against tuberculosis (Q36329910)

13 August 2017

1 reference

title

Prospects for a novel vaccine against tuberculosis (English)

1 reference

13 August 2017

0 references

Peter Andersen

3

0 references

author name string

Jes Dietrich

series ordinal

1

1 reference

PubMed ID

16325357

13 August 2017

Karin Weldingh

series ordinal

2

1 reference

13 August 2017

1 December 2005

1 reference

13 August 2017

7

1 reference

based on heuristic

inferred from page(s)

published in

Veterinary Microbiology

1 reference

13 August 2017

112

1 reference

13 August 2017

2-4

1 reference

13 August 2017

163-169

1 reference

Expression cloning of an immunodominant family of Mycobacterium tuberculosis antigens using human CD4(+) T cells

13 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETMIC.2005.11.030

Does the protective effect of neonatal BCG correlate with vaccine-induced tuberculin reaction?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETMIC.2005.11.030

The T cell response to secreted antigens of Mycobacterium tuberculosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETMIC.2005.11.030

Identification of immunodominant antigens during infection with Mycobacterium tuberculosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETMIC.2005.11.030

Susceptibility of mice deficient in CD1D or TAP1 to infection with Mycobacterium tuberculosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETMIC.2005.11.030

ESAT-6 subunit vaccination against Mycobacterium tuberculosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETMIC.2005.11.030

Failure of the Mycobacterium bovis BCG vaccine: some species of environmental mycobacteria block multiplication of BCG and induction of protective immunity to tuberculosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETMIC.2005.11.030

Preventing tuberculosis with bacillus Calmette-Guérin vaccine: a meta-analysis of the literature

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETMIC.2005.11.030

Specific T-cell epitopes for immunoassay-based diagnosis of Mycobacterium tuberculosis infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETMIC.2005.11.030

Efficacy of BCG vaccine in the prevention of tuberculosis. Meta-analysis of the published literature

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETMIC.2005.11.030

Disseminated tuberculosis in interferon gamma gene-disrupted mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETMIC.2005.11.030

Exchanging ESAT6 with TB10.4 in an Ag85B fusion molecule-based tuberculosis subunit vaccine: efficient protection and ESAT6-based sensitive monitoring of vaccine efficacy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETMIC.2005.11.030

Comparative Analysis of Different Vaccine Constructs Expressing Defined Antigens fromMycobacterium tuberculosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETMIC.2005.11.030

Interferon-gamma and interleukin-12 pathway defects and human disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETMIC.2005.11.030

Priming by DNA immunization augments protective efficacy of Mycobacterium bovis Bacille Calmette-Guerin against tuberculosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETMIC.2005.11.030

Variation in protection by BCG: implications of and for heterologous immunity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETMIC.2005.11.030

An essential role for interferon gamma in resistance to Mycobacterium tuberculosis infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETMIC.2005.11.030

Recombinant bacillus calmette-guerin (BCG) vaccines expressing the Mycobacterium tuberculosis 30-kDa major secretory protein induce greater protective immunity against tuberculosis than conventional BCG vaccines in a highly susceptible animal model

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETMIC.2005.11.030

The primary mechanism of attenuation of bacillus Calmette-Guerin is a loss of secreted lytic function required for invasion of lung interstitial tissue

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETMIC.2005.11.030

Immunization of mice with mycobacterial culture filtrate proteins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETMIC.2005.11.030

Immunogenicity and protective efficacy of a tuberculosis DNA vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETMIC.2005.11.030

Rapid detection of Mycobacterium tuberculosis infection by enumeration of antigen-specific T cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETMIC.2005.11.030

Efficacy of BCG vaccination of the newborn: evaluation by a follow-up study of contacts in Bangui

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETMIC.2005.11.030

Protection of macaques against Mycobacterium tuberculosis infection by a subunit vaccine based on a fusion protein of antigen 85B and ESAT-6

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETMIC.2005.11.030

Immunogenicity and efficacy of a tuberculosis DNA vaccine encoding the components of the secreted antigen 85 complex

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETMIC.2005.11.030

Recombinant modified vaccinia virus Ankara expressing antigen 85A boosts BCG-primed and naturally acquired antimycobacterial immunity in humans

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETMIC.2005.11.030

The relative importance of T cell subsets in immunity and immunopathology of airborne Mycobacterium tuberculosis infection in mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETMIC.2005.11.030

Identification and HLA restriction of naturally derived Th1-cell epitopes from the secreted Mycobacterium tuberculosis antigen 85B recognized by antigen-specific human CD4(+) T-cell lines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETMIC.2005.11.030

PPE protein (Rv3873) from DNA segment RD1 of Mycobacterium tuberculosis: strong recognition of both specific T-cell epitopes and epitopes conserved within the PPE family

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETMIC.2005.11.030

Protection of mice with a tuberculosis subunit vaccine based on a fusion protein of antigen 85b and esat-6.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETMIC.2005.11.030

Protective effect of a tuberculosis subunit vaccine based on a fusion of antigen 85B and ESAT-6 in the aerosol guinea pig model

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETMIC.2005.11.030

Recombinant BCG exporting ESAT-6 confers enhanced protection against tuberculosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETMIC.2005.11.030

Human T cell responses to the ESAT-6 antigen from Mycobacterium tuberculosis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETMIC.2005.11.030

Conclusive evidence that the major T-cell antigens of the Mycobacterium tuberculosis complex ESAT-6 and CFP-10 form a tight, 1:1 complex and characterization of the structural properties of ESAT-6, CFP-10, and the ESAT-6*CFP-10 complex. Implications

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETMIC.2005.11.030

CD1 and CD1-restricted T cells in infections with intracellular bacteria

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETMIC.2005.11.030

Epitope mapping of the immunodominant antigen TB10.4 and the two homologous proteins TB10.3 and TB12.9, which constitute a subfamily of the esat-6 gene family

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETMIC.2005.11.030

Comparative evaluation of low-molecular-mass proteins from Mycobacterium tuberculosis identifies members of the ESAT-6 family as immunodominant T-cell antigens

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETMIC.2005.11.030

CD8- and CD95/95L-dependent mechanisms of resistance in mice with chronic pulmonary tuberculosis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETMIC.2005.11.030

Control of latent Mycobacterium tuberculosis infection is dependent on CD8 T cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETMIC.2005.11.030

An esat6 knockout mutant of Mycobacterium bovis produced by homologous recombination will contribute to the development of a live tuberculosis vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETMIC.2005.11.030

Proteins released from Mycobacterium tuberculosis during growth.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETMIC.2005.11.030

Effective vaccination of mice against Mycobacterium tuberculosis infection with a soluble mixture of secreted mycobacterial proteins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETMIC.2005.11.030

inferred from DOI database lookup

7 January 2021

based on heuristic

Immunization with extracellular proteins of Mycobacterium tuberculosis induces cell-mediated immune responses and substantial protective immunity in a guinea pig model of pulmonary tuberculosis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETMIC.2005.11.030

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/J.VETMIC.2005.11.030

1 reference

13 August 2017

1 reference

PubMed ID

16325357